logo
Select company
Select metric
$ 2.31MCurrent Liabilities
VS
Market
91
Sector
91
Industry
89
History
100
$ 0.74Close
$ 0.58 - $ 3.8 52-Week Range
Ticker Information

Ticker

GTBP

Company Name

GT BIOPHARMA INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

GT BIOPHARMA INC - Current Liabilities Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

GTBP - LiabilitesC Historical data
DateCurrent Liabilities
6/30/2025$ 2.31M
3/31/2025$ 3.64M
12/31/2024$ 5.9M
9/30/2024$ 4.66M
6/30/2024$ 3.76M
3/31/2024$ 4.6M
12/31/2023$ 6.63M
9/30/2023$ 5.09M
6/30/2023$ 4.84M
3/31/2023$ 4.08M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • GT BIOPHARMA INC's latest trailing twelve months (TTM) LiabilitesC stands at $ 30.69M.
  • Over the past 5 years, GT BIOPHARMA INC's average LiabilitesC has been $ 8.02M.
  • The median LiabilitesC for GT BIOPHARMA INC during this period was $ 4.89M
  • GT BIOPHARMA INC reached its highest LiabilitesC over the past 5 years at $ 35.09M.
  • The lowest LiabilitesC recorded by GT BIOPHARMA INC in the same timeframe $ 2.31M

Definition of Current Liabilities

[Balance Sheet] The current (short-term) portion of [Liabilities] includes obligations that are due to be paid to creditors within one year, reported if the company operates a classified balance sheet that segments current and non-current [Liabilities]

GTBP - Current Liabilities, Last 5 years

$ 2.31M

Minimum

Jun 30, 2025

$ 35.09M

Maximum

Dec 31, 2020

$ 8.02M

Average

$ 4.89M

Median

LiabilitesC Benchmark Analysis

The chart above depicts the distribution of LiabilitesC for companies in the Total Stock Market. The average LiabilitesC of the companies is $ 121.07M with a standard deviation of $ 165.44M.
The following table provides additional summary stats:
LiabilitesC in the Market:
filtered constituents2.7K
min$ 0
max$ 679.46M
average$ 121.07M
median$ 41M
std$ 165.44M